Terms ending in 2039
Every in-force patent on Symrise AG's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,603,506 | Product Comprising a Plastic Container and a Substance Composition In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,572,352 | Method for Producing Sclareolide In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,786,570 | Dermatological Product In force · High confidence | Symrise AG | In force | High confidence | |
| US 12,031,106 | Use of 1-Ethyl-4,4-Dimethyl-CYCLOHEXANE Derivatives as Fragrances In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,918,679 | Active Mixure In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,801,210 | Retinol Replacement in Skin Treatment In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,938,208 | An Antimicrobial Mixture In force · High confidence | Symrise AG | In force | High confidence | |
| US 11,937,622 | Obtaining a Volatile Fraction from Juices or Alcoholic Beverages In force · High confidence | Symrise AG | In force | High confidence | |
| US 12,441,953 | Isomer Mixtures of Unsaturated Macrocyclic Musk Compounds In force · High confidence | Symrise AG | In force | High confidence | |
| US 12,193,441 | Antimicrobial Mixtures Comprising at Least One Hydroxyphenone Derivative In force · High confidence | Symrise AG | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.